tiprankstipranks
Trending News
More News >
Arovella Therapeutics Limited (AU:ALA)
ASX:ALA
Australian Market

Arovella Therapeutics Limited (ALA) Income Statement

Compare
17 Followers

Arovella Therapeutics Limited Income Statement

Last quarter (Q4 2025), Arovella Therapeutics Limited's total revenue was AU$-3.30M, a decrease of -12655.17% from the same quarter last year. In Q4, Arovella Therapeutics Limited's net income was AU$-6.05M. See Arovella Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 136.00KAU$ 17.00KAU$ 405.90KAU$ 295.81KAU$ 257.35K
Gross Profit
AU$ 136.00KAU$ -25.98KAU$ -3.00MAU$ 88.75KAU$ 34.60K
Operating Expenses
AU$ 11.34MAU$ 10.79MAU$ 6.68MAU$ 5.23MAU$ 3.74M
Depreciation and Amortization
AU$ 107.29KAU$ 42.98KAU$ 837.18KAU$ 551.49KAU$ 652.18K
EBITDA
AU$ -11.10MAU$ -10.63MAU$ -10.37MAU$ -7.87MAU$ -4.99M
Operating Income
AU$ -11.20MAU$ -10.81MAU$ -9.68MAU$ -7.59MAU$ -2.99M
Other Income/Expenses
AU$ 3.69MAU$ 2.07MAU$ -1.55MAU$ -1.02MAU$ -2.05M
Pretax Income
AU$ -7.51MAU$ -8.75MAU$ -11.23MAU$ -8.62MAU$ -5.05M
Net Income
AU$ -7.51MAU$ -8.75MAU$ -10.18MAU$ -8.62MAU$ -5.05M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.02AU$ -0.02
Diluted EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.02AU$ -0.02
Weighted Average Shares Outstanding
1.10B 941.42M 711.48M 549.62M 330.89M
Weighted Average Shares Outstanding (Diluted)
1.10B 941.42M 711.48M 549.62M 330.89M
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History